PharmaBoardroom

Interview with Charalambos Pattinis, CEO, Remedica

How do you explain that despite the Bolar exemption, a high number of scientists, a very educated population, and Europe’s lowest tax rate, Cyprus…

Interview with Dr. Chetan Tamhankar, Chief Executive Officer,…

Undeniably, the landscape for CROs has dramatically changed compared to when you started in the 1990s. The idea of having India as a clinical research…

Interview with Janusz Obukowicz, Managing Director,…

Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development…

Interview with Rita Bobro, Managing Director, Merck Russia

Merck KGaA describes itself as the world’s oldest pharmaceutical and chemicals company. What is the company’s history here in Russia? The…

Interview with Marina Veldanova, Country Manager, Ipsen Russia

Ipsen has recently announced the acquisition of a Russian pharmaceutical license. Even before this license, Russia was already one of the largest…

Interview with Daniel Ghozzi, Managing Director UCB CIS, UCB…

What were the difficulties in the CIS regions around the time of the financial crisis? Were there similarities to the situation in Russia? Yes, the…

Malaysia: The Overlooked Emerging Market

Without a doubt, Malaysia shares all the major attributes of an emerging market, from the potential to expand market penetration to the increasing…

Interview with Ivan Blanarik, General Director, Boehringer…

You have been with Boehringer Ingelheim since the early days of your career in 1994. In the pharmaceutical sector, managers seem to jump from company…

Interview with Maria Denisova, Senior Operations Manager, IMS…

You were the former director of RMBC, which was acquired in 2008 by the IMS. How important was this acquisition in terms of positioning the IMS on the…

Interview with Pawel Kacprzyk, President of The Board, Medicover

You became president of the board at Medicover in Poland only a while ago and previously your previous experience was in high-profile management but…

Interview with Girish L. Telang, Vice Chairman and Managing…

There is no doubt that India has become a country of rising opportunities. Can you first elaborate how important India has become for the Group…

Interview with Milos Petrovic, General Manager, Roche Moscow

Roche is the leading company in the ONLS (high-technology reimbursement) segment of the prescription drug market, and also the top oncology company in…

Tagged with